What are the ethical or legal risks of using AI to boost drug development?
Release Date:
Formation Bio, a startup with backing from Open AI CEO Sam Altman, has announced a raise of $372 million to boost drug development using artificial intelligence. But what are the potential ethical and legal risks associated with this?GUEST: Emily Casey, self-described Medicine Defector, Head of Community at Tenmile and Founder of ‘What the Health’
What are the ethical or legal risks of using AI to boost drug development?